🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of this study is to evaluate the tolerability and saf...
Status
Completed
Location
Eisai Trial Site 5
Start Date
2017-11-28
Trial ID
NCT03386942
Treatments Being Tested
The purpose of this study is to evaluate whether therapy with farletuzumab ...
Status
Withdrawn
Location
Emory University
Start Date
2011-02
Trial ID
NCT01203618
Treatments Being Tested
The purpose of the study is to assess the safety, tolerability, and efficac...
Status
Completed
Location
Local Institution - 0065
Start Date
2023-02-01
Trial ID
NCT05613088
Treatments Being Tested
MORAb-003 is intravenously administered to Japanese patients with folate re...
Status
Completed
Location
Multiple Locations
Start Date
2010-01
Trial ID
NCT01049061
Treatments Being Tested
The primary objectives of the study are: (1) in the dose-escalation part: t...
Status
Recruiting
Location
ACRC/Arizona Clinical Research Center, Inc
Start Date
2020-08-06
Trial ID
NCT04300556
Treatments Being Tested
This research is being done to find out if Carboplatin and Taxane works bet...
Status
Terminated
Location
University Of Alabama At Birmingham
Start Date
2009-04-16
Trial ID
NCT00849667
Treatments Being Tested
The purpose of this study is to determine if an investigational drug called...
Status
Completed
Location
Sharp HealthCare
Start Date
2006-05
Trial ID
NCT00318370
Treatments Being Tested
The primary objective of this study is to compare the effect of farletuzuma...
Status
Completed
Location
Ironwood Cancer and Research Center
Start Date
2011-06-27
Trial ID
NCT01218516
Treatments Being Tested
The study is being conducted to find out if paclitaxel works better when gi...
Status
Terminated
Location
Southern Cancer Center
Start Date
2008-09
Trial ID
NCT00738699
Treatments Being Tested
MORAb-003-011 is a global, multicenter, double-blind, randomized placebo-co...
Status
Completed
Location
Multiple Locations
Start Date
2015-03-19
Trial ID
NCT02289950
Treatments Being Tested